PAION
PAION is a biopharmaceutical company headquarted in Aachen, Germany. Since the acquisition of CeNes Pharmaceuticals, which was completed in June 2008, the company has a second site in Cambridge, UK.
The company is specializing in developing and commercializing innovative drugs for the hospital-based treatment of central nervous systems (CNS) disorders and thrombotic/cardiovascular diseases, indications for which there is a substantial unmet medical need.
PAION intends to further expand its portfolio of drugsby exploiting its core expertise in identifying high-potential compounds, licensing or otherwise acquiring them and advancing them through the clinical development and regulatory approval process.
PAION is listed at Frankfurt Stock Exchange (Prime Standard Regulated Market, Stock Symbol PA8, ISIN DE000A0B65S3).
